MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-33-0201696
Ataraxia Pharma Private Limited
Ataraxia Pharma Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹108.65 Cr
▲ 582% YoY
Net profit · FY 2025
₹1.88 Cr
Net margin 1.7%
EBITDA · FY 2025
₹3.61 Cr
EBITDA margin 3.3%
Authorised capital
₹5.15 Cr
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Open charges
₹1.5 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Ataraxia Pharma Private Limited
Data last updated:
Ataraxia Pharma Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC315902. Its GSTIN is 27AARCA4717E1ZL (Maharashtra).
The company has an authorised share capital of ₹5.15 Cr and a paid-up capital of ₹11 Lakh. It is led by directors Sani Malose and Akshay Anilrao Dalal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O M/S Empire Mall Private Limited Plot No P – 80 Iind Floor Gala No B – 3 – A, MIDC Chikalthana Industrial Area Chh. Sambhaji Nagar (Aurangabad), Maharashtra, India – 431007.
As per the financials filed for FY 2025, the company reported a revenue of ₹108.65 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.88 Cr (net margin 1.7%) and EBITDA of ₹3.61 Cr (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 343% over three years and 148% over five years.
As per MCA filings, the company has open charges of ₹1.5 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Ataraxia Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0201696). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2018PTC315902
Registration Number 315902
Incorporation Date 17 October 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0201696
Recognitions & Rankings of Ataraxia Pharma
Contact details
Ataraxia Pharma Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O M/S Empire Mall Private Limited Plot No P – 80 Iind Floor Gala No B – 3 – A, MIDC Chikalthana Industrial Area Chh. Sambhaji Nagar (Aurangabad), Maharashtra, India – 431007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ataraxia Pharma Private Limited, buy the company report.
Comprehensive company report
Ataraxia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ataraxia Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Ataraxia Pharma Private Limited, buy the company report.
Financials of Ataraxia Pharma Private Limited
FY 2024 filings availableAtaraxia Pharma Private Limited reported revenue of ₹108.65 Cr (up 582% YoY) for FY 2025.
Revenue · FY 2025
₹108.65 Cr ▲ 582%
Net profit · FY 2025
₹1.88 Cr margin 1.7%
EBITDA · FY 2025
₹3.61 Cr margin 3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 582%
3 years · compounded
▲ 343%
5 years · compounded
▲ 148%
EBITDA CAGR growth
1 year
▲ 733%
3 years · compounded
▲ 255%
5 years · compounded
▲ 184%
Revenue has grown at a compounded annual rate (CAGR) of 148% over five years, including 582% growth in the latest year. EBITDA rose 733% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.61 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.88 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ataraxia Pharma Private Limited, buy the company report.
Board of directors of Ataraxia Pharma Private Limited
Ataraxia Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sani Malose | Director | 17 Oct 2018 | 8 Years 0 Months | Current |
| Akshay Anilrao Dalal Also directs: Simpli Source Global Private Limited | Director | 29 Mar 2023 | 3 Years 6 Months | Current |
Auditor
Ataraxia Pharma Private Limited is audited by PRATIK THAKKAR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRATIK THAKKAR & CO | FY 2023 | 142297W |
Shareholding
The shareholding of Ataraxia Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ataraxia Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Sep 2024 | 100971132 | Others | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Ataraxia Pharma Private Limited has 1 court case on record: 1 filed by Ataraxia Pharma. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Aurangabad, Maharashtra | Civil suit | Filed by the company against Shrushti Pharmaceuticals Pvt Ltd and 1 other | Pending |
To see the full case history of Ataraxia Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ataraxia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ataraxia Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA4717E1ZL | Maharashtra | Active | 06 Jan 2019 |
To see the full GST registrations and return filing status of Ataraxia Pharma Private Limited, buy the company report.
Recent activity
Ataraxia Pharma Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Akshay Anilrao Dalal ceased to be Additional Director on 29 Sep 2023.
AGM
Ataraxia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100971132 was registered on 05 Sep 2024.
Filing
Ataraxia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Akshay Anilrao Dalal ceased to be Additional Director.
Appointed
Akshay Anilrao Dalal was appointed as Director.
Ceased
Avinash Bhaskarrao Malose ceased to be Director.
Appointed
Sani Malose was appointed as Director.
Incorporation
17 Oct 2018
Ataraxia Pharma Private Limited was registered on 17 Oct 2018 with Roc Mumbai & aged 8 years 7 days as per MCA records.
Frequently asked questions
Ataraxia Pharma is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 October 2018 (8+ years old) and is registered under CIN U74999MH2018PTC315902.
Ataraxia Pharma has 2 current directors:
- Sani Malose - Director
- Akshay Anilrao Dalal - Director
The latest financial statements of Ataraxia Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ataraxia Pharma is 27AARCA4717E1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ataraxia Pharma is U74999MH2018PTC315902. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ataraxia Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Ataraxia Pharma was incorporated on 17 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Akshay Anilrao Dalal ceased to be Additional Director on 29 Sep 2023. Akshay Anilrao Dalal was appointed as Director on 29 Mar 2023. Avinash Bhaskarrao Malose ceased to be Director on 29 Mar 2023. Ataraxia Pharma has 4 board changes on record in total.
Yes, Ataraxia Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0201696).
The registered office of Ataraxia Pharma is at CO MS Empire Mall Private Limited Plot No P – 80 Iind Floor Gala No B – 3 – A, MIDC Chikalthana Industrial Area Chh. Sambhaji Nagar Aurangabad, Maharashtra, India – 431007.